289
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study

ORCID Icon, , , , ORCID Icon, ORCID Icon, , ORCID Icon, , , , , ORCID Icon & show all
Pages 967-976 | Published online: 27 Apr 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Gema Requena, Alexandrosz Czira, Victoria Banks, Robert Wood, Theo Tritton, Catherine Castillo, Jie Yeap, Rosie Wild, Chris Compton, Kieran J Rothnie, Felix JF Herth, Jennifer K Quint & Afisi S Ismaila. (2023) Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2039-2054.
Read now
Maria Gabriella Matera, Barbara Rinaldi, Carmela Belardo & Mario Cazzola. (2022) Pharmacotherapy of LAMA/LABA inhaled therapy combinations for chronic obstructive pulmonary disease: a clinical overview. Expert Review of Clinical Pharmacology 15:11, pages 1269-1281.
Read now

Articles from other publishers (2)

Ching-Fu Weng, Chien-Chih Wu, Mei-Hsuan Wu & Fang-Ju Lin. (2023) Comparison of Clinical Outcomes Among Different Fixed-Dose Combinations of Long-Acting Muscarinic Antagonists and Long-Acting β2-Agonists in Patients With COPD. Chest 163:4, pages 799-814.
Crossref
Wei-Chun Huang, Chih-Yu Chen, Wei-Chih Liao, Biing-Ru Wu, Wei-Chun Chen, Chih-Yen Tu, Chia-Hung Chen & Wen-Chien Cheng. (2022) Differences in Pulmonary Function Improvement after Once-Daily LABA/LAMA Fixed-Dose Combinations in Patients with COPD. Journal of Clinical Medicine 11:23, pages 7165.
Crossref